Search
Search
Eyewire News: The Podcast
06.24.26
Ocular Therapeutix provides a key update on its NDA plans for wet AMD drug candidate Axpaxli; Thea US launches a first-of-its-kind eye gel for glaucoma; and there were several recent milestones reached in the clinical development of novel drugs for a variety of ocular conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
05.13.26
Future of Posterior TherapeuticsShow More
